anti-GM-CSF (Merck Serono)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-GM-CSF (Merck Serono)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionMacrophage colony stimulating factor 2 inhibitors
TargetsMacrophage colony stimulating factor 2
Therapy Area/IndicationsMultiple SclerosisArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Serono Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Serono Sa
Active IndicationsN/A
Inactive IndicationsMultiple SclerosisArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A